1. Home
  2. ASPN vs VNDA Comparison

ASPN vs VNDA Comparison

Compare ASPN & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aspen Aerogels Inc.

ASPN

Aspen Aerogels Inc.

HOLD

Current Price

$3.23

Market Cap

573.2M

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$7.84

Market Cap

474.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASPN
VNDA
Founded
2001
2002
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
573.2M
474.0M
IPO Year
2011
2005

Fundamental Metrics

Financial Performance
Metric
ASPN
VNDA
Price
$3.23
$7.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$4.25
$14.90
AVG Volume (30 Days)
1.7M
3.6M
Earning Date
05-25-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
125.76
N/A
EPS
N/A
N/A
Revenue
$452,699,000.00
$216,105,000.00
Revenue This Year
N/A
$21.50
Revenue Next Year
$38.29
$38.67
P/E Ratio
N/A
N/A
Revenue Growth
89.64
8.72
52 Week Low
$2.30
$3.81
52 Week High
$9.78
$9.60

Technical Indicators

Market Signals
Indicator
ASPN
VNDA
Relative Strength Index (RSI) 46.75 52.82
Support Level $2.89 $4.25
Resistance Level $3.80 $8.29
Average True Range (ATR) 0.27 0.53
MACD -0.01 0.07
Stochastic Oscillator 64.46 63.39

Price Performance

Historical Comparison
ASPN
VNDA

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: